Prot# OSI2542s: Multicenter Phase II Trial of OSI-774 (Erlotinib, Tarceva?) in Patients with Advanced Bronchioloalveolar Cell Lung Cancer (NU Prot# NU MSK03L1)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/5/04 → 12/8/11

Funding

  • Genentech, Inc. (OSI2542s)